Literature DB >> 21507550

Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.

Dana Vitner1, Michael Deutsch, Yuri Paz, Nizar Khatib, Tania Baltiter, Shiran Rosenberg, Lior Lowenstein.   

Abstract

OBJECTIVE: The study was aimed to evaluate the effectiveness, outcome, and pain intensity of the vaginal administration of misoprostol for the induction of abortion between 13 and 24 gestational weeks. STUDY
DESIGN: A retrospective study was conducted at our tertiary medical center from January 2006 to December 2009 on 122 consecutive women who underwent termination of pregnancy (TOP) in the mid-trimester. They were given 400 mcg of vaginal misoprostol every 6h, up to four doses. The induction-to-abortion interval and the level of pain experienced during the process were assessed. Success was defined by the fetus being expelled within 48 h.
RESULTS: Vaginal misoprostol was effective in 84% (98/122) of patients. The median duration of the induction-to-abortion interval was 16 (5-48)h. The induction-to-abortion interval was correlated with gestational age, while inversely correlated with parity. A correlation was also found between gestational age and pain intensity at 12h from induction.
CONCLUSION: Misoprostol is safe and effective in mid-trimester abortion induction. The induction-to-abortion interval is shorter and abortion less painful with lower gestational age. Higher parity is also associated with shorter induction to abortion interval.
Copyright © 2011. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507550     DOI: 10.1016/j.ejogrb.2010.12.035

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  1 in total

1.  Induced second trimester abortion and associated factors in Amhara region referral hospitals.

Authors:  Amlaku Mulat; Hinsermu Bayu; Habtamu Mellie; Amare Alemu
Journal:  Biomed Res Int       Date:  2015-03-30       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.